Literature DB >> 18309340

Adult vitreous structure and postnatal changes.

M M Le Goff1, P N Bishop.   

Abstract

This review will focus on the molecular organisation of the adult vitreous and how it undergoes ageing changes throughout life that result in vitreous liquefaction and a predisposition towards posterior vitreous detachment and retinal break formation. At birth, the vitreous humour is in a gel state due to the presence of a network of fine collagen fibrils. With ageing, these collagen fibrils progressively aggregate due to a loss of type IX collagen from their surfaces. The aggregation of collagen fibrils may cause vitreous liquefaction which, when combined with an age-related weakening of postbasal vitreoretinal adhesion, predisposes to posterior vitreous detachment. Throughout postnatal life, the posterior border of the vitreous base migrates posteriorly from the ora serrata into the peripheral retina. This is due to new collagen synthesis by the peripheral retina. This new collagen intertwines with pre-existing cortical vitreous collagen to create new adhesions and thereby extends the vitreous base posteriorly. If irregularities in the posterior border of the vitreous base arise from this process, there is a predisposition towards retinal break formation during posterior vitreous detachment and subsequent rhegmatogenous retinal detachment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18309340     DOI: 10.1038/eye.2008.21

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  68 in total

1.  Are ancient proteins responsible for the age-related decline in health and fitness?

Authors:  Roger John Willis Truscott
Journal:  Rejuvenation Res       Date:  2010-02       Impact factor: 4.663

2.  Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications.

Authors:  Henry F Edelhauser; Cheryl L Rowe-Rendleman; Michael R Robinson; Daniel G Dawson; Gerald J Chader; Hans E Grossniklaus; Kay D Rittenhouse; Clive G Wilson; David A Weber; Baruch D Kuppermann; Karl G Csaky; Timothy W Olsen; Uday B Kompella; V Michael Holers; Gregory S Hageman; Brian C Gilger; Peter A Campochiaro; Scott M Whitcup; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-11       Impact factor: 4.799

3.  Vitreous substitutes: challenges and directions.

Authors:  Qian-Ying Gao; Yue Fu; Yan-Nian Hui
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

4.  The liberation of CD44 intracellular domain modulates adenoviral vector transgene expression.

Authors:  Cristhian J Ildefonso; Wesley S Bond; Azza R Al-Tawashi; Mary Y Hurwitz; Richard L Hurwitz
Journal:  J Biol Chem       Date:  2012-08-03       Impact factor: 5.157

Review 5.  Drug and gene delivery to the back of the eye: from bench to bedside.

Authors:  Cheryl L Rowe-Rendleman; Shelley A Durazo; Uday B Kompella; Kay D Rittenhouse; Adriana Di Polo; Alan L Weiner; Hans E Grossniklaus; Muna I Naash; Alfred S Lewin; Alan Horsager; Henry F Edelhauser
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-28       Impact factor: 4.799

6.  Effective and sustained delivery of hydrophobic retinoids to photoreceptors.

Authors:  Peter H Tang; Jie Fan; Patrice W Goletz; Lee Wheless; Rosalie K Crouch
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-23       Impact factor: 4.799

Review 7.  In Vivo Stability of Therapeutic Proteins.

Authors:  Joachim Schuster; Atanas Koulov; Hanns-Christian Mahler; Pascal Detampel; Joerg Huwyler; Satish Singh; Roman Mathaes
Journal:  Pharm Res       Date:  2020-01-03       Impact factor: 4.200

8.  Proteomic analysis of vitreous biopsy techniques.

Authors:  Jessica M Skeie; Eric N Brown; Harryl D Martinez; Stephen R Russell; Emily S Birkholz; James C Folk; H Culver Boldt; Karen M Gehrs; Edwin M Stone; Michael E Wright; Vinit B Mahajan
Journal:  Retina       Date:  2012 Nov-Dec       Impact factor: 4.256

9.  Age-dependent deamidation of lifelong proteins in the human lens.

Authors:  Peter G Hains; Roger J W Truscott
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

10.  A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.

Authors:  Henrik Barth; Sven Crafoord; Sten Andréasson; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-08       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.